Merck Group

Science and technology in healthcare, life science, performance materials.

Launch date

1668

Employees

Market cap

Net debt

$1.2b

Firm valuation

$241.3b (Public information from Aug 2022)

Darmstadt Hesse (HQ)

https://www.merckgroup.com/en

https://twitter.com/merckgroup https://www.facebook.com/emdgroup https://www.linkedin.com/company/1485

Deals in current and previous year:

- view all undefined

Corporate Venture Fund: M. Ventures

Revenues, earnings & profits over time

USD	2016	2017	2018	2019	2020	2021	2022E
Revenues	-	40.1b	42.3b	46.8b	48.0b	48.7b	57.4b
% growth	-	-	5 %	11 %	2 %	1 %	18 %
EBITDA	-	15.1b	15.8b	19.6b	20.6b	19.8b	24.0b
% EBITDA margin	-	38 %	37 %	42 %	43 %	41 %	42 %
Profit	-	2.6b	6.2b	9.8b	7.1b	13.0b	15.8b
% profit margin	-	6 %	15 %	21 %	15 %	27 %	28 %
EV / revenue	-	4.2x	5.1x	5.3x	4.8x	4.0x	3.5x
EV / EBITDA	-	11.2x	13.6x	12.6x	11.2x	10.4x	8.4x

Date	Investors	Amount	Round
Jan 2002	N/A	N/A	IPO
Total Funding		-

By Country

United States 5 Switzerland 1 Germany 1

By Industry

By Round

ACQUISITION 5 POST IPO EQUITY 1 SERIES H 1

Idenix Pharmaceuticals

ACQUISITION by Merck Group Jun 2014

Moderna Therapeutics

exited

Threshold Pharmaceuticals

ACQUISITION by Molecular Templates Aug 2017

Cubist Pharmaceuticals

ACQUISITION by Merck Group Dec 2014

Chord Therapeutics

ACQUISITION by Merck Group Dec 2021

ACQUISITION by Merck Group Jan 2022

ACQUISITION by Merck Group Jan 2021